Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
作者： Mahboobeh Safaeian , Carolina Porras , Yuanji Pan , Aimee Kreimer , John T. Schiller
DOI: 10.1158/1940-6207.CAPR-13-0203
关键词:
摘要: … Most antiviral prophylactic vaccines are thought to function … The commercial HPV prophylactic vaccines provide an … array of 72 pentamers of the L1 major capsid protein that structurally …
aacrjournals.org
sci-hub.se 参考文章(31)
H. J. Hinton, A. Jegerlehner, M. F. Bachmann, Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors. Current Topics in Microbiology and Immunology. ,vol. 319, pp. 1- 15 ,(2008) , 10.1007/978-3-540-73900-5_1
David FitzSimons, Greet Hendrickx, Alex Vorsters, Pierre Van Damme, Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011. Vaccine. ,vol. 31, pp. 584- 590 ,(2013) , 10.1016/J.VACCINE.2012.10.101
Cecilia M Roteli-Martins, Paulo Naud, Paola De Borba, Julio C Teixeira, Newton S De Carvalho, Toufik Zahaf, Nervo Sanchez, Brecht Geeraerts, Dominique Descamps, None, Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine : up to 8.4 years of follow-up Human Vaccines & Immunotherapeutics. ,vol. 8, pp. 390- 397 ,(2012) , 10.4161/HV.18865
Ian J. Amanna, Mark K. Slifka, Mechanisms that determine plasma cell lifespan and the duration of humoral immunity Immunological Reviews. ,vol. 236, pp. 125- 138 ,(2010) , 10.1111/J.1600-065X.2010.00912.X
John T. Schiller, Xavier Castellsagué, Suzanne M. Garland, A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines Vaccine. ,vol. 30, ,(2012) , 10.1016/J.VACCINE.2012.04.108
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
MF Bachmann, U Kalinke, A Althage, Giulia Freer, C Burkhart, H-P Roost, M Aguet, H Hengartner, RM Zinkernagel, The Role of Antibody Concentration and Avidity in Antiviral Protection Science. ,vol. 276, pp. 2024- 2027 ,(1997) , 10.1126/SCIENCE.276.5321.2024
Gary T. Jennings, Martin F. Bachmann, The coming of age of virus-like particle vaccines. Biological Chemistry. ,vol. 389, pp. 521- 536 ,(2008) , 10.1515/BC.2008.064
Petra Lenz, Douglas?R. Lowy, John?T. Schiller, Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells European Journal of Immunology. ,vol. 35, pp. 1548- 1556 ,(2005) , 10.1002/EJI.200425547
Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Grégory Catteau, Kurt Dobbelaere, Anne Schuind, Dominique Descamps, Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from a randomized study Human Vaccines. ,vol. 7, pp. 1374- 1386 ,(2011) , 10.4161/HV.7.12.18322